Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab’s Place in COVID-19 Pneumonia
media
posted on 2021-07-08, 16:10 authored by Adis Rapid Journals on behalf of:, Timothée Klopfenstein, Vincent Gendrin, Aurélie Gerazime, Thierry Conrozier, Jean-Charles Balblanc, Pierre-Yves Royer, Anne Lohse, Chaouki Mezher, Lynda Toko, Cerise Guillochon, Julio Badie, Alix Pierron, N’dri Juliette Kadiane-Oussou, Marc Puyraveau, Souheil Zayet<p><strong>Article full
text</strong></p>
<p><br></p><p>
The above summary slide represents the opinions of
the <b>authors</b>. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC <b>2021</b>.<b>
</b></p>
History
Related Materials
- 1.
- 2.
